Balchem Co. (NASDAQ:BCPC) Shares Bought by Inspire Advisors LLC

Inspire Advisors LLC boosted its stake in shares of Balchem Co. (NASDAQ:BCPC) by 3.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,123 shares of the basic materials company’s stock after acquiring an additional 161 shares during the quarter. Inspire Advisors LLC’s holdings in Balchem were worth $835,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Westside Investment Management Inc. acquired a new position in shares of Balchem during the 3rd quarter valued at about $27,000. R Squared Ltd purchased a new stake in Balchem in the fourth quarter valued at approximately $29,000. Wilmington Savings Fund Society FSB purchased a new stake in Balchem in the third quarter valued at approximately $35,000. Venturi Wealth Management LLC acquired a new position in Balchem during the fourth quarter worth $95,000. Finally, Smartleaf Asset Management LLC boosted its position in shares of Balchem by 230.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company’s stock worth $106,000 after buying an additional 450 shares during the period. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Balchem Stock Performance

NASDAQ:BCPC opened at $169.20 on Wednesday. The firm has a market capitalization of $5.50 billion, a PE ratio of 43.05, a price-to-earnings-growth ratio of 4.41 and a beta of 0.63. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. The business’s fifty day moving average price is $163.30 and its 200 day moving average price is $169.86. Balchem Co. has a 12 month low of $137.69 and a 12 month high of $186.03.

Balchem (NASDAQ:BCPC) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.11 by ($0.08). The business had revenue of $240.00 million for the quarter, compared to analysts’ expectations of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. On average, sell-side analysts anticipate that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on BCPC shares. Sidoti raised Balchem to a “hold” rating in a research report on Tuesday, February 25th. HC Wainwright reaffirmed a “buy” rating and set a $190.00 target price on shares of Balchem in a research note on Monday, February 24th. Finally, StockNews.com cut shares of Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.